National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M02AA15	OLFEN	G	Diclofenac sodium (diethylamine) - 1%	1%	Gel	268,769 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	1,169,143 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	717,612 L.L
C05AE03	DILTIGEL	G	Diltiazem HCl - 2%	2%	Gel	632,950 L.L
M02AA15	DILO	G	Diclofenac sodium - 2%	2%	Gel	267,489 L.L
D10AF02	SPOTEX	G	Erythromycin - 4%	4%	Gel	854,684 L.L
D10AF05	NAXIDERM	G	Nadifloxacin - 1%	1%	Gel	826,783 L.L
C05BA53	CONTRACTUBEX	B	Allantoin - 1g/100g, Cepae - 10g/100g, Heparin - 5000IU/100g		Gel	498,566 L.L
D10AF51	DUAC ONCE DAILY	B	Clindamycin (phosphate) - 1%, Benzoyl peroxide - 5%		Gel	1,658,302 L.L
C05BA53	CONTRACTUBEX	B	Allantoin - 1g/100g, Cepae - 10g/100g, Heparin - 5,000IU/100g		Gel	1,183,925 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 2%	2%	Gel	588,603 L.L
D11AX18	ALMIRAL	G	Diclofenac sodium - 1% w/w	1% w/w	Gel	396,434 L.L
D11AX18	LABDIC RELIEF	G	Diclofenac sodium - 1%w/w, Methyl salicylate - 8%w/w, Menthol - 2%w/w		Gel	263,393 L.L
D01AC02	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	427,470 L.L
D01AC08	KETOCONAZOLE KORHISPANA	G	Ketoconazole - 2%	2%	Gel	599,354 L.L
A02BX02	SUCRATE GEL	G	Sucralfate - 1g	1g	Gel	636,981 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
D02AF	REPARIL GEL-N	B	Diethylamine salicylate - 5g/100g, Ascine - 1g/100g		Gel	481,096 L.L
R06AB02	HISTAMED	G	Dexchlorpheniramine maleate - 1%	1%	Gel	477,384 L.L
D03AX06	BECAPLEX	BioTech	Becaplermin - 40mg	0.01%	Gel	38,029,953 L.L
D04AA13	FENISTIL	B	Dimethindene maleate - 1mg/g	1mg/g	Gel	196,201 L.L
G03DA04	CRINONE	B	Progesterone - 8%	8%	Gel	4,734,357 L.L
G03DA04	PROGESTOGEL	B	Progesterone - 1%	1%	Gel	542,912 L.L
G03DA04	PROGESTOGEL	B	Progesterone - 1%	1%	Gel	542,912 L.L
G03DA04	DARSTIN	G	Progesterone - 10mg/g	10mg/g	Gel	380,307 L.L
D05AX52	DAIVOBET	B	Calcipotriol - 50mcg/g, Betamethasone - 0.5mg/g		Gel	2,100,426 L.L
D05AX52	BETA-CAL	G	Calcipotriol (monohydrate) - 50mcg/g, Betamethasone (dipropionate) - 0.5mg/g		Gel	1,251,117 L.L
D06AX08	TYROSUR	G	Tyrothricin - 1mg/g	1mg/g	Gel	510,660 L.L

National Cancer Registry (NCR)